Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) Customer Breakdown

PHATHOM PHARMACEUTICALS, INC. Customer Breakdown

Customer relationships and concentrations across all retained periods. Named customers and their revenue are shown when disclosed. Anonymous customers, customer groups and sales channels are labelled separately. Receivable concentration measures unpaid balances, not revenue contribution. A biggest customer by revenue can be identified only from disclosed customer revenue. Missing names and amounts remain missing; identities are not assumed to match between periods.

Period / as ofCustomer / groupCategoryCustomer revenueShare of revenueShare of trade receivablesBasis and limitations

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46